Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02019069. IPD Sharing: NO. Countries: 1. Publications: 0.
FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02392429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05168202. IPD Sharing: Not stated. Countries: 9. Publications: 0.
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02666950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
ClinicalTrials.gov study NCT00509093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02873338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02665143. IPD Sharing: NO. Countries: 1. Publications: 0.
Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02029417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00528398. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03118466. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01342887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously T
ClinicalTrials.gov study NCT03146871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00398983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07370064. IPD Sharing: NO. Countries: 1. Publications: 0.
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02714790. IPD Sharing: YES. Countries: 0. Publications: 1.
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
ClinicalTrials.gov study NCT04146038. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04742101. IPD Sharing: YES. Countries: 6. Publications: 0.
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
ClinicalTrials.gov study NCT03012672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02257138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02096042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.